Evidence map›Paper›PMID 20368404›Full record

ArticleAntimicrobial agents and chemotherapy2010

Discovery of a gene conferring multiple-aminoglycoside resistance in Escherichia coli.

Margaret A Davis, Katherine N K Baker, Lisa H Orfe, Devendra H Shah, Thomas E Besser, Douglas R Call

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
4.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 107 citations in OpenAlex.

  1. Article
  2. Article
  3. Genomic Characterization of Carbapenemase-ProducingAntibiotics (Basel, Switzerland) · 2024
    Article
  4. Article
  5. Article
  6. Review
  7. Ribosome-targeting antibiotics and resistanceRSC medicinal chemistry · 2023
    Review
  8. Article
  9. Early Years of Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2022
    Article
  10. Review
  11. Article
  12. Extraintestinal PathogenicAntibiotics (Basel, Switzerland) · 2022
    Review
  13. Article
  14. Molecular survey of aminoglycoside-resistantNew microbes and new infections · 2021
    Article
  15. Review
  16. Article
  17. Article
  18. Characteristics of Carbapenem-ResistantFrontiers in microbiology · 2018
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Margaret A DavisDepartment of Veterinary Microbiology and Pathology, Washington State University, Pullman, WA 99164-7040, USA. madavis@vetmed.wsu.edu
Katherine N K Baker
Lisa H Orfe
Devendra H Shah
Thomas E Besser
Douglas R Call
Washington State University · US

Funding

PHS HHS N01-A1-30054PHS HHS N01-A1-30055
6 · The paper itself

Abstract

Bovine-origin Escherichia coli isolates were tested for resistance phenotypes using a disk diffusion assay and for resistance genotypes using a DNA microarray. An isolate with gentamicin and amikacin resistance but with no corresponding genes detected yielded a 1,056-bp DNA sequence with the closest homologues for its inferred protein sequence among a family of 16S rRNA methyltransferase enzymes. These enzymes confer high-level aminoglycoside resistance and have only recently been described in Gram-negative bacteria.

Indexed as

Genes, BacterialAnimalsBase SequenceCattleDNA, BacterialDNA PrimersDrug Resistance, Multiple, BacterialEscherichia coliIn Vitro TechniquesMethyltransferasesOligonucleotide Array Sequence AnalysisPhylogenyRNA, BacterialRNA, Ribosomal, 16SDNA, BacterialDNA PrimersMethyltransferasesRNA, BacterialRNA, Ribosomal, 16SrRNA (adenosine-O-2'-)methyltransferase

Identifiers

PMID20368404
PMCPMC2876372
OpenAlexW2138829352

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.